Chia Nan University of Pharmacy & Science Institutional Repository:Item 310902800/34603
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 18074/20272 (89%)
Visitors : 4075471      Online Users : 982
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/34603


    Title: 5-Demethylnobiletin Inhibits Cell Proliferation, Downregulates ID1 Expression, Modulates the NF-κB/TNF-α Pathway and Exerts Antileukemic Effects in AML Cells
    Authors: Chen, Pei-Yi
    Wang, Chih-Yang
    Tsao, En-Ci
    Chen, Yu-Ting
    Wu, Ming-Jiuan
    Ho, Chi-Tang
    Yen, Jui-Hung
    Contributors: Buddhist Tzu Chi General Hospital
    Hualien Tzu Chi Hospital
    Tzu Chi University
    Taipei Medical University
    Taipei Medical University
    Department of Biotechnology, Chia Nan University of Pharmacy & Science
    Rutgers System
    Rutgers New Brunswick
    Tzu Chi University
    Keywords: cancer
    polymethoxyflavones
    proteins
    citrus
    carcinogenesis
    metabolites
    apoptosis
    nobiletin
    promotes
    drugs
    Date: 2022
    Issue Date: 2023-12-11 14:00:18 (UTC+8)
    Publisher: MDPI
    Abstract: Acute myeloid leukemia (AML) is characterized by the dysregulation of hematopoietic cell proliferation, resulting in the accumulation of immature myeloid cells in bone marrow. 5-Demethylnobiletin (5-demethyl NOB), a citrus 5-hydroxylated polymethoxyflavone, has been reported to exhibit various bioactivities, such as antioxidant, anti-inflammatory and anticancer properties. In this study, we investigated the antileukemic effects of 5-demethyl NOB and its underlying molecular mechanisms in human AML cells. We found that 5-demethyl NOB (20-80 mu M) significantly reduced human leukemia cell viability, and the following trend of effectiveness was observed: THP-1 approximate to U-937 > HEL > HL-60 > K562 cells. 5-Demethyl NOB (20 and 40 mu M) modulated the cell cycle through the regulation of p21, cyclin E1 and cyclin A1 expression and induced S phase arrest. 5-Demethyl NOB also promoted leukemia cell apoptosis and differentiation. Microarray-based transcriptome, Gene Ontology (GO) and Gene Set Enrichment Analysis (GSEA) of differentially expressed genes (DEGs) analysis showed that the expression of inhibitor of differentiation/DNA binding 1 (ID1), a gene associated with the GO biological process (BP) cell population proliferation (GO: 0008283), was most strongly suppressed by 5-demethyl NOB (40 mu M) in THP-1 cells. We further demonstrated that 5-demethyl NOB-induced ID1 reduction was associated with the inhibition of leukemia cell growth. Moreover, DEGs involved in the hallmark gene set NF-kappa B/TNF-alpha signaling pathway were markedly enriched and downregulated by 5-demethyl NOB. Finally, we demonstrated that 5-demethyl NOB (20 and 40 mu M), combined with cytarabine, synergistically reduced THP-1 and U-937 cell viability. Our current findings support that 5-demethyl NOB dramatically suppresses leukemia cell proliferation and may serve as a potential phytochemical for human AML chemotherapy.
    Relation: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, v.23, n.13, 7392CB2
    Appears in Collections:[Dept. of Biotechnology (including master's program)] Periodical Articles

    Files in This Item:

    File Description SizeFormat
    ijms23137392.pdf12453KbAdobe PDF204View/Open
    index.html0KbHTML209View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback